Regentis Biomaterials Ltd. (RGNT) stock
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.84−0.30 (-26.34%)
Close on Nov 19, 2026Market cap $4.35MP/E –Yield –
Regentis Biomaterials gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Regentis Biomaterials
Regentis Biomaterials has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?